RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Efficacy Maintained When Transitioning Directly from TNF Inhibitor to Tofacitinib in RA
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 8
SP 8
OP 9
DO 10.1177/155989771308004
UL http://mdc.sagepub.com/content/13/8/8.abstract
AB Patients with rheumatoid arthritis (RA) who transition directly from adalimumab to tofacitinib maintained a clinical response. This article presents results from the open-label extension Oral Rheumatoid Arthritis Phase 3 Trials Sequel study [ORAL; NCT00413699] of the randomized, double-blind, placebo-controlled ORAL Standard study in which the two treatments were compared in patients with active RA [NCT00853385].